drugset / Trial / NCT04285281

Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome

NCT04285281

Phase 4 Completed 126 enrolled Universidad Europea de Madrid
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The present randomized clinical trial will perform a comparison of the pain reduction effects produced by the application of a non invasive and non pharmacological median nerve neural mobilization (physiotherapy treatment), to those effects produced by Gabapentin and the absence of treatment, in subjects who suffer the signs and symptoms of carpal tunnel syndrome.

Timeline

Start
2020-04-01
Primary completion
2020-08-01
Completion
2020-08-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 300 mg Oral